Director's approve five to one share consolidation

Vancouver, British Columbia, May 13, 2022. Lexston Life Sciences Corp. (the “Company” or “Lexston”) (CSE: LEXT) (OTCQB: LEXTF) announces that its board of directors approved the consolidation of the common shares of the Company on the ratio of five (5) pre-consolidated shares for one (1) postconsolidated share. The effective date and timing of the share consolidation will be determined and announced at a later date.

On Behalf of the Board of Directors LEXSTON LIFE SCIENCES CORP.

Jagdip Bal Chief Executive Officer Telephone: (604) 928-8913

The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.

929 Mainland Street Phone (604) 928-8913 Vancouver, BC V6B 1S3 Fax (604) 628-0129 Email [email protected] Website www.lexston.ca